International Congress on Targeted Therapies in Cancer®
International Congress on Targeted Therapies in Cancer® October 2022
International Congress on Targeted Therapies in Cancer
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Priority Review to Gedatolisib for Advanced Breast Cancer
2
FDA Grants BTD to Sofetabart Mipitecan for Platinum-Resistant Ovarian Cancer
3
RFS Benefit Sustained at 5 Years for Intismeran Autogene in Melanoma
4
3 Trials Refine Endocrine, HER2-Targeted Therapies at SABCS
5